IL151667A0 - A METHOD OF PRODUCING IgG - Google Patents
A METHOD OF PRODUCING IgGInfo
- Publication number
- IL151667A0 IL151667A0 IL15166701A IL15166701A IL151667A0 IL 151667 A0 IL151667 A0 IL 151667A0 IL 15166701 A IL15166701 A IL 15166701A IL 15166701 A IL15166701 A IL 15166701A IL 151667 A0 IL151667 A0 IL 151667A0
- Authority
- IL
- Israel
- Prior art keywords
- igg
- igg fraction
- iii
- fraction
- derived
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0001128A SE0001128D0 (sv) | 2000-03-30 | 2000-03-30 | A method of producing IgG |
PCT/EP2001/003624 WO2001072844A2 (fr) | 2000-03-30 | 2001-03-29 | Procédé de production d'igg |
Publications (1)
Publication Number | Publication Date |
---|---|
IL151667A0 true IL151667A0 (en) | 2003-04-10 |
Family
ID=20279068
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL15166701A IL151667A0 (en) | 2000-03-30 | 2001-03-29 | A METHOD OF PRODUCING IgG |
Country Status (15)
Country | Link |
---|---|
US (1) | US6835379B2 (fr) |
EP (1) | EP1268551B1 (fr) |
JP (1) | JP2003530326A (fr) |
CN (1) | CN1419566A (fr) |
AT (1) | ATE260297T1 (fr) |
AU (2) | AU2001273907B2 (fr) |
BR (1) | BRPI0109740B8 (fr) |
CA (1) | CA2402784A1 (fr) |
DE (1) | DE60102144T2 (fr) |
IL (1) | IL151667A0 (fr) |
PT (1) | PT1268551E (fr) |
RU (1) | RU2266914C2 (fr) |
SE (1) | SE0001128D0 (fr) |
TR (1) | TR200400701T4 (fr) |
WO (1) | WO2001072844A2 (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100451031C (zh) * | 2003-09-05 | 2009-01-14 | 东丽株式会社 | 生物体成分组成改变了的溶液的调制方法 |
WO2005028500A1 (fr) * | 2003-09-05 | 2005-03-31 | Toray Industries, Inc. | Procede de preparation d'une solution comportant une composition de composants biologiques |
EP1532983A1 (fr) | 2003-11-18 | 2005-05-25 | ZLB Bioplasma AG | Preparation d'immunoglobulines à stabilité élevée |
TWI391399B (zh) | 2005-05-25 | 2013-04-01 | Hoffmann La Roche | 測定溶離多肽之鹽濃度之方法 |
US8293242B2 (en) * | 2005-09-01 | 2012-10-23 | Plasma Technologies, Llc | Ultra-high yield of alpha-1-anti-trypsin |
US20070049732A1 (en) * | 2005-09-01 | 2007-03-01 | Zurlo Eugene J | Ultra-high yield intravenous immune globulin preparation |
US7879332B2 (en) * | 2005-09-01 | 2011-02-01 | Plasma Technologies, Llc | Ultra-high yield intravenous immune globulin preparation |
CN100362022C (zh) * | 2005-11-07 | 2008-01-16 | 中国人民解放军第二军医大学 | 海螵蛸多糖cps-1及其制备方法和用途 |
US20070128693A1 (en) * | 2005-12-06 | 2007-06-07 | Advantek Serum Laboratories Limited3/F | Method for the inactivation and removal of dengue virus from biological samples |
WO2007136327A1 (fr) * | 2006-05-22 | 2007-11-29 | Ge Healthcare Bio-Sciences Ab | Procédé de production d'igg |
US20100158893A1 (en) * | 2008-12-19 | 2010-06-24 | Baxter International Inc. | Systems and methods for obtaining immunoglobulin from blood |
MY157239A (en) | 2009-05-27 | 2016-05-13 | Baxalta Inc | A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use |
JP5984676B2 (ja) | 2009-12-18 | 2016-09-06 | シーエスエル、リミテッド | ポリペプチドを精製する方法 |
WO2011090720A2 (fr) * | 2009-12-29 | 2011-07-28 | Dr. Reddy's Laboratories Ltd | Purification des protéines |
KR101912169B1 (ko) | 2010-02-04 | 2018-10-26 | 체에스엘 베링 아게 | 면역글로불린 제제 |
EP2361636A1 (fr) | 2010-02-26 | 2011-08-31 | CSL Behring AG | Préparation d'immunoglobuline et système de stockage pour préparation d'immunoglobuline |
AU2010202125B1 (en) | 2010-05-26 | 2010-09-02 | Takeda Pharmaceutical Company Limited | A method to produce an immunoglobulin preparation with improved yield |
US8796430B2 (en) | 2010-05-26 | 2014-08-05 | Baxter International Inc. | Method to produce an immunoglobulin preparation with improved yield |
US8772462B2 (en) | 2010-05-26 | 2014-07-08 | Baxter International Inc. | Removal of serine proteases by treatment with finely divided silicon dioxide |
MY165164A (en) * | 2011-08-26 | 2018-02-28 | Baxalta Inc | Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
TWI629283B (zh) | 2012-02-23 | 2018-07-11 | 巴克斯歐塔公司 | 來自血漿中的免疫球蛋白之i-iv-1部分沉澱 |
DK3590960T3 (da) | 2012-02-29 | 2023-04-24 | Takeda Pharmaceuticals Co | Igg-stimuleret remyelinisering af perifere nerver |
AU2013203043B2 (en) | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
FR3018450B1 (fr) * | 2014-03-11 | 2016-04-15 | Lab Francais Du Fractionnement | Procede de preparation de proteines plasmatiques humaines |
CN104231065A (zh) * | 2014-09-09 | 2014-12-24 | 青岛康大食品有限公司 | 兔血中球蛋白的纯化制备方法 |
WO2017066683A1 (fr) | 2015-10-15 | 2017-04-20 | Plasma Technologies, Llc | Procédés d'extraction de protéines à partir de plasma sanguin |
MX2018009331A (es) * | 2016-02-03 | 2018-11-09 | Plasma Tech Llc | Metodos para extraer proteinas a partir de un material a base de sangre. |
CA3149777A1 (fr) * | 2019-09-20 | 2021-03-25 | Eugene ZURLO | Compositions de proteines therapeutiques et procedes correspondants |
US10815270B1 (en) * | 2019-09-20 | 2020-10-27 | Plasma Technologies, Llc | Compositions and methods for high efficiency protein precipitation |
IL296778A (en) | 2020-03-31 | 2022-11-01 | Takeda Pharmaceuticals Co | A method for producing an immunoglobulin composition from diluted c-1 inhibitor plasma |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3927111C3 (de) * | 1989-08-17 | 1994-09-01 | Biotest Pharma Gmbh | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate |
EP0447585B2 (fr) * | 1990-03-22 | 2003-05-07 | Biotest Pharma Gmbh | Procédé de production d'une préparation tolérante d'immunoglobuline G intraveineuse |
DE4118912C1 (fr) * | 1991-06-08 | 1992-07-02 | Biotest Pharma Gmbh, 6072 Dreieich, De | |
DE59309332D1 (de) * | 1993-12-27 | 1999-03-04 | Rotkreuzstiftung Zentratrallab | Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält |
US5429746A (en) * | 1994-02-22 | 1995-07-04 | Smith Kline Beecham Corporation | Antibody purification |
US5886154A (en) * | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
IL121900A (en) | 1997-10-07 | 2001-12-23 | Omrix Biopharmaceuticals Ltd | A method for the purification of immunoglobulins |
DK2272870T3 (da) * | 1998-06-09 | 2013-08-05 | Csl Behring Ag | Fremgangsmåde til fremstilling af immunoglobuliner med henblik på intravenøs indgivelse og andre immunoglobulin-lignende produkter. |
ATE277950T1 (de) | 1998-06-09 | 2004-10-15 | Statens Seruminstitut | Verfahren zur herstellung von immunoglobulinen zur intravenösen verabreichung und anderen immunoglobulin-produkten |
DE19923027C2 (de) * | 1999-05-19 | 2002-09-19 | Aventis Behring Gmbh | Verfahren zur Inaktivierung von Viren |
-
2000
- 2000-03-30 SE SE0001128A patent/SE0001128D0/xx unknown
-
2001
- 2001-03-29 US US10/220,929 patent/US6835379B2/en not_active Expired - Lifetime
- 2001-03-29 WO PCT/EP2001/003624 patent/WO2001072844A2/fr active IP Right Grant
- 2001-03-29 EP EP20010940271 patent/EP1268551B1/fr not_active Expired - Lifetime
- 2001-03-29 CA CA002402784A patent/CA2402784A1/fr not_active Abandoned
- 2001-03-29 BR BRPI0109740A patent/BRPI0109740B8/pt not_active IP Right Cessation
- 2001-03-29 AU AU2001273907A patent/AU2001273907B2/en not_active Ceased
- 2001-03-29 DE DE60102144T patent/DE60102144T2/de not_active Expired - Fee Related
- 2001-03-29 PT PT01940271T patent/PT1268551E/pt unknown
- 2001-03-29 TR TR2004/00701T patent/TR200400701T4/xx unknown
- 2001-03-29 CN CN01807338A patent/CN1419566A/zh active Pending
- 2001-03-29 RU RU2002124857/04A patent/RU2266914C2/ru not_active IP Right Cessation
- 2001-03-29 AT AT01940271T patent/ATE260297T1/de not_active IP Right Cessation
- 2001-03-29 JP JP2001571775A patent/JP2003530326A/ja active Pending
- 2001-03-29 IL IL15166701A patent/IL151667A0/xx not_active IP Right Cessation
- 2001-04-02 AU AU7390701A patent/AU7390701A/xx active Pending
Also Published As
Publication number | Publication date |
---|---|
SE0001128D0 (sv) | 2000-03-30 |
RU2002124857A (ru) | 2004-02-20 |
DE60102144T2 (de) | 2004-10-28 |
RU2266914C2 (ru) | 2005-12-27 |
AU7390701A (en) | 2001-10-08 |
EP1268551A2 (fr) | 2003-01-02 |
US20030143222A1 (en) | 2003-07-31 |
ATE260297T1 (de) | 2004-03-15 |
CA2402784A1 (fr) | 2001-10-04 |
BR0109740A (pt) | 2003-02-04 |
BR0109740B1 (pt) | 2015-01-06 |
DE60102144D1 (de) | 2004-04-01 |
AU2001273907B2 (en) | 2006-02-02 |
JP2003530326A (ja) | 2003-10-14 |
WO2001072844A2 (fr) | 2001-10-04 |
CN1419566A (zh) | 2003-05-21 |
EP1268551B1 (fr) | 2004-02-25 |
US6835379B2 (en) | 2004-12-28 |
BRPI0109740B8 (pt) | 2021-05-25 |
TR200400701T4 (tr) | 2004-05-21 |
PT1268551E (pt) | 2004-07-30 |
WO2001072844A3 (fr) | 2002-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL151667A0 (en) | A METHOD OF PRODUCING IgG | |
TW245768B (en) | Method for killing microorganisms | |
JPH0231689A (ja) | 百日咳トキシンの精製法 | |
ATE346861T1 (de) | Verfahren zur reinigung und isolierung von viren, aus pflanzenquellen | |
CA2156007A1 (fr) | Purification d'un inhibiteur d'alpha-1 proteinase grace a de nouvelles conditions de separation par chromatographie | |
CA2557229A1 (fr) | Procede de realisation d'une preparation anticorps avirale purifiee | |
JP2007533660A5 (fr) | ||
FR2737730B1 (fr) | Procede de purification de virus par chromatographie | |
ATE163043T1 (de) | Reinigungsmethode und entsprechende vorrichtung | |
IL108144A0 (en) | Non-reducing saccharideforming enzyme, its preparation and uses | |
PL347472A1 (en) | Process for purifying human papillomavirus virus-like particles | |
FR2539629B1 (fr) | Procede de production d'air sterile pour usage medical et installation pour la mise en oeuvre de ce procede | |
JPS5944320A (ja) | C1不活性化剤の調製方法 | |
CA2244095A1 (fr) | Procede de production d'un catalyseur pour l'epuration des gaz d'echappement | |
SI9420008B (sl) | Postopek za izdelavo koncentrata anti-D imunoglobulina G in farmacevtski pripravek ,ki ga vsebuje | |
WO2003034982A3 (fr) | Procede de purification a rendement eleve d'immuno-globulines a partir de plasma sanguin et d'intermediaires de plasma sanguin | |
WO2004015144A3 (fr) | Systeme de purification de jus | |
EP1376021A4 (fr) | Systeme d'apport d'air, procede de desinfection de l'air, et systeme et procede de transfert | |
RU2006118024A (ru) | Способ удаления вирусов из жидкой композиции, содержащей фактор vii | |
DE3465015D1 (en) | Process for the production of a solution of igg-immunoglobulin free of secondary effect for intravenous application | |
CN1181782A (zh) | 一种从生物原料中制备因子ix的方法 | |
AU2002359583A1 (en) | An exhaust treatment and filtration system for molten carbonate fuel cells | |
EP1078911A3 (fr) | Procédé de purification fine d'une solution aqueuse contenant un acide organique obtenu par fermentation | |
TWI584810B (zh) | 缺乏一種以上致血栓因子的血漿製品之製備方法 | |
JPS5758629A (en) | Separating and purifying method of colonization stimulating factor and callicrein in human urine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
MM9K | Patent not in force due to non-payment of renewal fees |